Research Overview

Drug Discovery

Drug Discovery's vision is to develop log scale improvements to accelerate and de-risk the process of drug discovery, with the long-term goal of doubling the success rate in clinical development. The program objective is to propel BII to the leading edge of transformative computational innovation in bringing new medicines to patients, ranging from the discovery of novel disease targets to the design & optimization of therapeutics and the selection of patient populations, as well as positioning the institute as a premier hub for public-private collaboration in biopharma, attracting sustained research funding and generating high-impact assets with both commercial and societal value.

Cellular Biotech

Cellular Biotech program's mission is to pioneer the research and development of AI-powered and data-driven biotechnologies, including novel data analytics platforms, AI/ML models, markers, or assays, as well as their translation and commercialization and into practical solutions for disease modeling and diagnosis, chemical/biomolecule assessments, therapeutic development, and precision medicine

The program's current scientific focuses include:

1. Multi-modal AI models, foundation models, digital twins, or other advanced AI methods for disease modeling and target discovery and therapeutic development
2. Predictive and automated in vitro or in silico assays, markers, or tools for disease diagnosis, chemical/biomolecule assessment, and precision medicine Data management and analytics platforms for cellular/tissue images, biochemical assays, mass spectra, and molecular structures

AI for Health